|
|
Publicaciones
Savio E, Fagiolino P, Solanas G, Parente E, León A
Development of w/o Phenytoin emulsions. Bioavailability in rats
Science et Technique pharmaceutique: STP Pharma Sciences, 1-6: 379-385
(1991)
Savio E, Gambino D, León A, Kremer C, Kremer E
Electrolytic 99mTc04 reduction: a different pathway to obtain 99mTc
complexes
Appl Radiat Isotopes, Int J Radiat Appl Instrum, Part A 42-7:
669-672 (1991)
Fagiolino P, Savio E, Stareczec S
Linear relationships in systems with non linear kinetics
Eur J Drug Metab Pharmacokinet (Special issue N3): 485-496 (1991)
León A, Fagiolino P, Savio E, Vazquez M
Bioavailability of a Phenytoin w/o emulsion in humans (II)
STP Pharma Sciences, 2-5: 415-419 (1992)
Vazquez M, Fagiolino P, Savio E
Utilización de niveles salivales en estudios de biodisponibilidad
Rev Org Ibero-Latinoam Farm (OFIL), 2-1: 10-14 (1992)
Savio E, Fagiolino P, Parrillo S, Aiache JM.
Biodisponibilidad de una microemulsión de fenitoína en
voluntarios sanos
Acta Farm Bonaerense, 13-2: 79-83 (1994)
Savio E, Fagiolino P, Jelen M, León AS
Influence of the emulsion sign in phenytoin bioavailability
Boll Chim Farm, 133-4: 239-245 (1994)
Leon ET, Rey AM, Savio EO, Lopez JJ, Kremer E, Leon AS
99mTc-ADP: a potential agent for in vivo tumor detection
J Nucl Biol Med, 38: 99-103 (1994)
Savio E, Nieto A
Ovine toxoplasmosis: seroconversion during pregnancy and lamb birth rate in Uruguayan sheep flocks
Vet Parasitol, 60: 241-247 (1995)
Gaudiano J, León A, Verdera S, Martinez G, Leon E, Savio E, Roble A, Muñiz S
Primeras experiencias con (Re-188)HEDP para terapia de metástasis
óseas
Rev Esp Med Nucl, 14(5): 352 (1995)
González S, Teran M, Leon E, Savio E, León A, Nieto A
Assessment of the diagnostic value of 99m Tc-radiolabelled specific
antibodies in experimental hydatidosis
Q J Nucl Med, 40-2: 161-169 (1996)
León A, Rey A, Leon E, Savio E, Kremer C, Lacava CJ, Nappa A, Chiozzone R, Campos E
Labelling, control and radiopharmacological evaluation of 99mTc-ADP
as tumour seeking agent
Q J Nucl Med, 40(2): 170-175 (1996)
Verdera S, Gaudiano J, León A, Martinez G, Robles A, Savio E, Leon E, McPherson DW, Knapp F
Rhenium-188-HEDP-Kit formulation and quality control
Radiochim Acta, 219: 1-5 (1997)
Fagiolino P, Vazquez M, Savio E, Dominguez L,
Aiache JM, Beyssac E, Cardot JM
Average parameters in bioavailability studies: an application to slow-release amitriptyline formulation
Eur J Drug Metab Pharmacokinet, 23:-160-165 (1998)
Savio E, Dominguez L, Malanga A, Quevedo D, Saldana J, Camarote C, Ochoa A, Fagiolino P
Lipidic matrix of albendazole: an alternative for systemic infections
Boll Chim Farm, 137: 345-349 (1998)
Dominguez L, Savio E, Saldana J, Malanga A, Quevedo D, Camarote C, Ochoa A, Fagiolino P
Lipidic matrix of albendazole sulphoxide: is it an alternative for systemic infections?
Boll Chim Farm, 137: 383-386 (1998)
Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, Savio EO, Paulusma-Annema A, Pauwels EK, Nibbering PH
99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections
J Nucl Med, 42:788-794 (2001)
Savio E, Gaudiano J, Robles AM, Balter H, Paolino A, Lopez A, Hermida JC, De Marco E, Martinez G, Osinaga E, Knapp FF Jr
Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
BMC Nucl Med, 1: 2 (2001)
|
Investigadores
:
